UA116719U - METHOD OF ACTIVATIVE THERAPY OF IMMUNODEFICIENCY CONDITIONS IN ONCOLOGICAL DISEASES - Google Patents
METHOD OF ACTIVATIVE THERAPY OF IMMUNODEFICIENCY CONDITIONS IN ONCOLOGICAL DISEASESInfo
- Publication number
- UA116719U UA116719U UAU201702697U UAU201702697U UA116719U UA 116719 U UA116719 U UA 116719U UA U201702697 U UAU201702697 U UA U201702697U UA U201702697 U UAU201702697 U UA U201702697U UA 116719 U UA116719 U UA 116719U
- Authority
- UA
- Ukraine
- Prior art keywords
- taking
- days
- epam
- day
- novomin
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Спосіб активаційної терапії імунодефіцитних станів при онкологічних захворюваннях, що включає прийом пацієнтом біологічно активного препарату АСД-2 за схемою, конкретне виконання якої визначають за критеріями досягнення оптимального клінічного ефекту, причому додатково приймають комплексні біологічно активні препарати Новомін, ЕПАМ-7 та ЕПАМ-31, препарат АСД-2 приймають 1 раз на день натще за 45 хвилин до прийому їжі протягом перших 25 днів по 5-30 крапель за визначеною схемою, при цьому через кожні 5 днів прийому препарату роблять терапевтичну паузу, Новомін приймають по 2 капсули 2 рази на день протягом 30 днів починаючи з другого тижня прийому АСД-2, ЕПАМ-7 приймають по 10 крапель сублінгвально під час їжі 2 рази на день протягом 30 днів починаючи з другого тижня прийому Новоміна, ЕПАМ-31 приймають по 10 крапель сублінгвально під час їжі 2 рази на день протягом 30 днів починаючи з другого тижня прийому ЕПАМ-7 при загальному курсі лікування 7 тижнів.Method of activation therapy of immunodeficiency states in oncological diseases, including patient taking biologically active drug ASD-2 according to the scheme, the specific implementation of which is determined by the criteria of achieving optimal clinical effect, and additionally taking complex biologically active drugs Novomin, EPAM-7 and EPA the drug ASD-2 is taken once a day on an empty stomach 45 minutes before meals for the first 25 days for 5-30 drops according to a certain scheme, with every 5 days of taking the drug make a therapeutic break, Novomin take 2 capsules 2 times a day for 30 days from the second week of taking ASD-2, EPAM-7 take 10 drops sublingually with food 2 times a day for 30 days from the second week of taking Novomin, EPAM-31 take 10 drops sublingually during meals 2 times per day for 30 days from the second week of taking EPAM-7 with a total course of treatment of 7 weeks.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201702697U UA116719U (en) | 2017-03-23 | 2017-03-23 | METHOD OF ACTIVATIVE THERAPY OF IMMUNODEFICIENCY CONDITIONS IN ONCOLOGICAL DISEASES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201702697U UA116719U (en) | 2017-03-23 | 2017-03-23 | METHOD OF ACTIVATIVE THERAPY OF IMMUNODEFICIENCY CONDITIONS IN ONCOLOGICAL DISEASES |
Publications (1)
Publication Number | Publication Date |
---|---|
UA116719U true UA116719U (en) | 2017-05-25 |
Family
ID=74104992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAU201702697U UA116719U (en) | 2017-03-23 | 2017-03-23 | METHOD OF ACTIVATIVE THERAPY OF IMMUNODEFICIENCY CONDITIONS IN ONCOLOGICAL DISEASES |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA116719U (en) |
-
2017
- 2017-03-23 UA UAU201702697U patent/UA116719U/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chang et al. | Medial prefrontal cortex activation facilitates re-extinction of fear in rats | |
AR109103A1 (en) | TREATMENT OF FABRY'S DISEASE IN PATIENTS NOT TREATED AND PREVIOUSLY TREATED WITH ERT | |
RU2018103081A (en) | WAYS OF TREATMENT OF COLITES | |
MX2016009231A (en) | Administration of tasimelteon under fasted conditions. | |
RU2018125622A (en) | METHOD OF APPLICATION OF CARRYMICIN AGAINST RESISTANCE OF INFECTION PROVIDED BY MYCOBACTERIA TUBERCULOSIS | |
PH12017500392A1 (en) | Medical treatments based on anamorelin | |
BR112019004210A2 (en) | pharmaceutical composition, method and kit for treatment of growth hormone deficiency | |
UA116719U (en) | METHOD OF ACTIVATIVE THERAPY OF IMMUNODEFICIENCY CONDITIONS IN ONCOLOGICAL DISEASES | |
JOP20170044B1 (en) | Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency | |
Yu et al. | Parkinson’s Disease | |
UA116484U (en) | METHOD OF TREATMENT OF HYPERTENSION WITH METABOLIC SYNDROME | |
UA114320U (en) | METHOD OF CONSERVATIVE TREATMENT OF TENDINOPATHIES OF THE HIDDEN MUSCLES | |
UA114594U (en) | METHOD OF TREATMENT OF PSORIASIS WITH CONCENTRAL ARTERIAL HYPERTENSION | |
SABARIAH | Cholestatic hepatitis: case report | |
Nakajima | Crawling sensation in an elderly patient: case report | |
UA127590U (en) | METHOD OF TREATMENT OF PSORIASIS PATIENTS | |
RU2012115056A (en) | METHOD FOR TREATING PATIENTS WITH OVERBODY WEIGHT AND DISTURBANCES | |
Cosme | Amoxicillin/clarithromycin/metronidazole/omeprazole | |
Zheng | Prednisolone/steroids | |
Cernadas | Hypersensitivity reaction with subsequent desensitisation: case report | |
Pfutzner | Benzylpenicillin/clindamycin/penicillins | |
Al-Kathiri | Photo-onycholysis: case report | |
Kawano | Osteonecrosis of the right femur: case report | |
RU2018110031A (en) | METHOD OF TREATMENT AND PREVENTION OF INFLUENZA | |
UA116487C2 (en) | METHOD OF TREATMENT OF PUSH-INFLAMMATORY PROCESSES BY ANTIMicrobials |